Unibios Holdings S.A (BIOSK) — Capital Reinvestment Ratio
Latest as of June 2023:
0.01x
Unibios Holdings S.A (BIOSK) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow (€372.03K) in capital expenditures (€2.27K). See BIOSK free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
€372.03K
EUR
Capital Expenditures
€2.27K
EUR
Data as of
Jun 2023
Most recent filing
Unibios Holdings S.A Capital Reinvestment Ratio (2014–2025)
This chart tracks Unibios Holdings S.A's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Unibios Holdings S.A (2014–2025)
Year-by-year Capital Reinvestment Ratio for Unibios Holdings S.A from 2014 to 2025. For live market cap and broader valuation context, see BIOSK market cap.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.94x | €546.05K | €2.15 Million | ▼ -32.8% |
| 2024 | 5.86x | €149.43K | €874.96K | ▲ +2183.7% |
| 2023 | 0.26x | €869.22K | €222.86K | ▲ +454.8% |
| 2021 | 0.05x | €1.06 Million | €48.98K | ▼ -99.8% |
| 2017 | 21.21x | €51.58K | €1.09 Million | ▲ +19880.2% |
| 2015 | 0.11x | €292.00K | €31.00K | ▲ +33.5% |
| 2014 | 0.08x | €264.00K | €21.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow